Innovative Medicines Canada statement on proposed pharmacare legislation
Ottawa, February 29, 2024 – Innovative Medicines Canada (IMC) is concerned with the federal government’s intent in Bill C-64, An […]
Pharmacare
Ensuring equitable access to medicines for all Canadians.
IMC and our members support government’s efforts to increase access to medicines for all Canadians – regardless of age, income, or where they live in Canada. A national pharmacare program must build on the strengths of our current dual-market system and focus on improving access for those who need it most: the uninsured and underinsured.
News
Sounding board: Private health insurance industry needs to innovate to keep offering value to Canadians
This article was originally posted on Benefits Canada on August 12, 2022. There’s no question that Canadians value their private […]
Building resilience in Canada’s health care system
This article originally appeared in The Globe and Mail on May 18, 2022. Health crises tend to reveal health inequities […]
Newsroom
Breaking down and analyzing current events in the healthcare industry for our members, policy influencers and the Canadian public.
About
Our member companies, which range from early-stage startups to established organizations, are revolutionizing healthcare through the discovery and development of new […]
